Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis

Show other versions (1)

BACKGROUND AND OBJECTIVES: Evidence suggests that sustained virologic response to interferon treatment decreases incidence of hepatocellular carcinoma in patients with hepatitis C virus cirrhosis. This study was designed to compare the incidence of hepatocellular carcinoma among cirrhotic patients e...

Full description

Bibliographic Details
Main Authors:	Nelson Cheinquer, Hugo Cheinquer, Fernando H Wolff, Silvia Coelho-Borges
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Subjects:	hepatocellular carcinoma HCV interferon sustained virologic response cirrhosis
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000500006&lng=en&tlng=en

Similar Items

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
by: Nelson Cheinquer, et al.
Published: (2010-09-01)

Clinical case of difficult differential diagnosis between liver cirrhosis and hepatocellular carcinoma associated with HCV infection in a patient with prolonged alcohol exposure
by: Baramzina S.V.
Published: (2019-12-01)

Effect of HFE gene polymorphism on sustained virological response in patients with chronic hepatitis C and elevated serum ferritin
by: Silvia Coelho-Borges, et al.
Published: (2012-03-01)

Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C
by: Tseng CW, et al.
Published: (2016-03-01)

Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis
by: Hafiza Arooba Riaz, et al.
Published: (2023-05-01)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
by: Pellicelli Adriano M, et al.
Published: (2012-11-01)

Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
by: Francesco Paolo Russo, et al.
Published: (2022-01-01)

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis
by: Georges-Philippe Pageaux, et al.
Published: (2022-01-01)

Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics
by: Luca Rinaldi, et al.
Published: (2020-05-01)

The Impact of Cirrhosis and History of Hepatocellular Carcinoma on All-Cause Mortality After Eradication of Hepatitis C Virus in Patients With Chronic Hepatitis C
by: Hidenori Toyoda, et al.
Published: (2022-01-01)

Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis
by: Steven Flamm, et al.
Published: (2023-09-01)

Hepatocellular carcinoma after a sustained virological response by direct‐acting antivirals harbors TP53 inactivation
by: Taisuke Imamura, et al.
Published: (2022-04-01)

Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
by: Jarosław Koza, et al.
Published: (2017-12-01)

Diffuse infiltrative hepatocellular carcinoma or cirrhosis?
by: Jarosław Koza, et al.
Published: (2017-12-01)

Hepatitis C Virus Serologic and Virologic Tests and Clinical Diagnosis of HCV-Related Liver Disease
Published: (2006-04-01)

Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma
by: I. A. Goncharova, et al.
Published: (2023-03-01)

Genomic Relevance of <i>FGFR2</i> on the Prognosis of HCV-Induced Hepatocellular Carcinoma Patients
by: Walizeb Khan, et al.
Published: (2022-05-01)

Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon
by: Sandro da Costa Ferreira, et al.

Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals
by: Federica Vernuccio, et al.
Published: (2022-05-01)

Role of bile acids in the prediction of hepatocellular carcinoma in HCV-induced liver cirrhosis
by: Ashraf Khalil, et al.
Published: (2021-09-01)

NON-INVASIVE TOOLS TO ASSESS THE RISK OF VARICES-NEEDING-TREATMENT IN CIRRHOSIS SECONDARY TO HCV
by: Laima Alam, et al.
Published: (2021-02-01)

Splenectomy in cirrhosis with hypersplenism: improvement in cytopenias, child's status and institution of specific treatment for hepatitis C with success
by: Saurabh Kedia, et al.
Published: (2012-11-01)

Role of IL-28B polymorphisms in virologic response to combined pegylated interferon and ribavirin therapy in genotype 4 chronic HCV infected patients with and without cirrhosis
by: Amira Youssef Shaala, et al.
Published: (2015-09-01)

Possible diagnostic role of microRNA-122 in chronic HCV infection and hepatocellular carcinoma
by: Asmaa Thabet, et al.
Published: (2023-05-01)

HCV Reactivation in a Patient with Hepatocellular Carcinoma Due to Sorafenib: A Case Report
by: Cheng J, et al.
Published: (2024-02-01)

PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma
by: Silvano Fasolato, et al.
Published: (2020-09-01)

Synchronous Hepatocellular Carcinoma and Cholangiocarcinoma in a Patient Transplanted for Cryptogenic Cirrhosis
by: B Geramizadeh, et al.
Published: (2014-07-01)

Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples
by: Shrikant Dasharath Warkad, et al.
Published: (2018-07-01)

Angiogenesis in liver cirrhosis and hepatocellular carcinoma
by: Amarapurkar Anjali, et al.
Published: (2008-07-01)

Sustained virological response after ten days of triple anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon and ribavirin in an HIV/HCV co-infected cirrhotic woman
by: Hamid Hasson, et al.
Published: (2014-12-01)

Impact of sustained virologic response in regression of portal hypertension in Egyptian patients with hepatitis C virus-associated cirrhosis and portal hypertension
by: Heba Ahmed Faheem, et al.
Published: (2022-04-01)

L3 Skeletal Muscle Index Dynamics in Patients with HCV-Related Compensated Cirrhosis Following Sustained Virological Response after Direct Acting Antiviral Treatment
by: Florin Mihai, et al.
Published: (2021-11-01)

Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin
by: Ng KJ, et al.
Published: (2016-08-01)

A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular Carcinoma
by: Krizia Pocino, et al.
Published: (2021-12-01)

Persistent epigenetic alterations in transcription factors after a sustained virological response in hepatocellular carcinoma
by: Keishi Sugimachi, et al.
Published: (2022-12-01)

The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity
by: Winston Stauffer, et al.
Published: (2023-10-01)

Daily Aspirin Reduced the Incidence of Hepatocellular Carcinoma and Overall Mortality in Patients with Cirrhosis
by: Chern-Horng Lee, et al.
Published: (2023-05-01)

Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study
by: Ji Hyun Kim, et al.
Published: (2020-11-01)

Low-Cost Predictors for Liver Function and Clinical Outcomes after Sustained Virological Response in Patients with HCV-Related Cirrhosis and Thrombocytopenia
by: Secil Omer, et al.
Published: (2023-01-01)

Treatment of hepatitis C virus infection: From therapy with interferon to direct-acting antivirals
by: Laura Lopera, et al.
Published: (2023-01-01)